Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.

Saved in:
Bibliographic Details
Title: Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
Authors: Moreno GM; From the University of California San Diego, La Jolla., Gandhi R; From the University of California San Diego, La Jolla., Lessig SL; From the University of California San Diego, La Jolla., Wright B; From the University of California San Diego, La Jolla., Litvan I; From the University of California San Diego, La Jolla., Nahab FB; From the University of California San Diego, La Jolla. fnahab@ucsd.edu.
Source: Neurology [Neurology] 2018 Oct 23; Vol. 91 (17), pp. 797-799. Date of Electronic Publication: 2018 Sep 26.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1526-632X
DOI:10.1212/WNL.0000000000006396